At the beginning of the Spring Festival, DeepSeek quickly became popular, and then the topic of AI software predicting the future became a hot topic, sparking discussions among netizens. Similar topics such as "using DeepSeek to predict the future development direction of the pharmaceutical industry", "predicting the top ten golden tracks for medical devices in 2025", and "predicting the investment trend in the medical device industry in 2025" are constantly emerging. Is AI prediction reliable?

To explore this question and continue the AI speculation, in DeepSeek's eyes, who will be the top 10 most valuable innovative medical devices in China? Today we will pose this question to DeepSeek, using its intelligent analysis to examine the current development status of innovative medical devices in China.

DeepSeek defines innovative medical devices
Value evaluation criteria for innovative medical devices - According to the Special Approval Procedure for Innovative Medical Devices, selected products must meet the following core conditions: ①Core technology autonomy: Products must be based on the independent intellectual property rights (invention patents or usage rights) of local Chinese enterprises, with internationally leading technology or filling domestic gaps; ② Significant clinical value: fundamental breakthroughs in performance, safety, or diagnostic and therapeutic efficiency, addressing unmet clinical needs; ③R&D maturity: Preliminary research has been completed and a finalized product has been formed, with data traceability;④ Quality controllability: meets safety and effectiveness requirements, and undergoes a rigorous review process.

Based on the above standards, combined with the 2024 medical device industry innovation ecological assessment and enterprise dynamics, the following are 10 local innovative medical device projects that have not yet been listed in China but have high value:
Top 10 Innovative Medical Devices in DeepSeek's Perspective
1. Project Name: Third Generation Fluorescent Microscope
R&D company: Mingzhun Medical
Scope of application: Three dimensional pathological analysis (such as tumor microenvironment research)
Project highlight: The first domestically produced 3D pathological imaging equipment with sub cellular resolution, supporting rapid imaging of living tissues.
Reasons for being listed: Breaking through foreign technological monopolies, filling the gap in domestic 3D pathology equipment, and promoting precision medicine research.

2. Project name: Dual frequency intravascular ultrasound diagnostic system
R&D company: Haoying Medical
Scope of application: Cardiovascular diseases
Project highlight: The world's first to achieve ultra-high frequency (60MHz) and dual frequency fusion imaging, which can clearly identify the layered structure of blood vessel walls.
Reason for inclusion: Strong innovation in engineering technology, improving the accuracy of interventional treatment for coronary heart disease.

3. Project Name: Extracorporeal Maglev Artificial Heart
R&D company: Xinqing Medical
Scope of application: Used to provide temporary left ventricular extracorporeal mechanical circulation assistance support for patients who cannot withdraw after cardiac surgery for no more than 30 days, as a transitional treatment before restoring cardiac function or deciding to adopt long-term replacement therapy.
Project highlights: Adopting magnetic levitation technology to reduce blood damage, supporting long-term extracorporeal circulation, and extending navigation for up to 30 days.
Reason for inclusion: The technology has reached the international leading level, providing new solutions for the transition of heart transplantation.

4. Project Name: Porous Endoscopic Surgical Robot
R&D company: KONOSTENG
Scope of application: Used for laparoscopic surgery in urology.
Project highlight: The world's second company to achieve dual platform coverage of porous and single hole robots, with a robotic arm accuracy of 0.1mm.
Reason for inclusion: Breaking the monopoly of da Vinci robots and reducing surgical costs.

5. Project name: Single molecule gene sequencer
R&D company: Zhenmai Biotechnology
Scope of application: Non invasive prenatal genetic testing, etc
Project highlight: No need for PCR amplification, direct reading of long DNA fragments with an accuracy rate of over 99.9%.
Reason for being listed: Breaking through the bottleneck technology and achieving a leap in the performance of domestic gene sequencers.

6. Project Name: Transcatheter tricuspid valve repair system
R&D company: Deke Medical
Scope of application: tricuspid regurgitation
Project highlight: The first domestically produced femoral vein repair instrument, reducing the surgical time to 1 hour.
Reason for inclusion: Addressing the risks of open chest surgery for elderly patients and filling the gap in the field of tricuspid valve intervention.

7. Project Name: Nanoscale Tumor Targeted Delivery System
R&D company: Nano Titanium Medical
Scope of application: Improve the delivery efficiency of anti-tumor drugs, etc
Project highlight: Utilizing magnetic nanoparticles to achieve precise drug localization, increasing efficacy by 40% and reducing side effects by 50%.
Reason for inclusion: Promoting the translation of tumor targeted therapy from laboratory to clinical use.

8. Project Name: Intelligent Orthopedic Surgery Navigation System
Research and development enterprise: Yuanhua Intelligence
Scope of application: Joint replacement, spinal surgery
Project highlight: AI real-time planning of surgical paths with an error of less than 0.5mm, supporting 5G remote operation.
Reason for inclusion: Improve the standardization level of complex orthopedic surgeries and reduce the learning curve for doctors.

9. Project Name: Degradable Brain Nerve Stimulation Electrode
R&D company: Mailiu Technology
Scope of application: epilepsy, Parkinson's disease, etc
Project highlight: The material can naturally degrade in the body, avoiding secondary surgical removal and improving stimulation accuracy by 30%.
Reason for inclusion: Combining innovative materials with neural regulation technology to promote clinical applications of neuroscience.

10. Project Name: Fully Automated Pathogen Microbial Detection Platform
R&D company: Yuguo Biotechnology
Scope of application: Automated pathogen detection and analysis
Project highlight: Complete pathogen identification and drug sensitivity analysis within 2 hours, covering over 1500 pathogens.
Reason for inclusion: Addressing the issue of low timeliness in traditional testing and aiding in precise treatment of infections.

Value embodiment of innovative equipment
The above projects are all led by local Chinese enterprises in research and development, covering high barrier fields such as imaging diagnosis, minimally invasive surgery, genetic testing, etc. The core technology has independent intellectual property rights and is at the forefront of the international community. After these devices are launched in the future, they will promote the process of domestic substitution, reduce medical costs, and improve the diagnosis and treatment level of major diseases.

Source: https://news.yaozh.com/archive/45004.html